Preservation of complex I function during hypoxia-reoxygenation-induced mitochondrial injury in proximal tubules.
Inhibition of complex I has been considered to be an important contributor to mitochondrial dysfunction in tissues subjected to ischemia-reperfusion. We have investigated the role of complex I in a severe energetic deficit that develops in kidney proximal tubules subjected to hypoxia-reoxygenation and is strongly ameliorated by supplementation with specific citric acid cycle metabolites, including succinate and the combination of -ketoglutarate plus malate. NADH: ubiquinone reductase activity in the tubules was decreased by only 26% during 60-min hypoxia and did not change further during 60-min reoxygenation. During titration of complex I activity with rotenone, progressive reduction of NAD+ to NADH was detected at >20% complex I inhibition, but substantial decreases in ATP levels and mitochondrial membrane potential did not occur until >70% inhibition. NAD+ was reduced to NADH during hypoxia, but the NADH formed was fully reoxidized during reoxygenation, consistent with the conclusion that complex I function was not limiting for recovery. Extensive degradation of cytosolic and mitochondrial NAD(H) pools occurred during either hypoxia or severe electron transport inhibition by rotenone, with patterns of metabolite accumulation consistent with catabolism by both NAD+ glycohydrolase and pyrophosphatase. This degradation was strongly blocked by alpha-ketoglutarate plus malate. The data demonstrate surprisingly little sensitivity of these cells to inhibition of complex I and high levels of resistance to development of complex I dysfunction during hypoxia-reoxygenation and indicate that events upstream of complex I are important for the energetic deficit. The work provides new insight into fundamental aspects of mitochondrial pathophysiology in proximal tubules during acute renal failure.
Feldkamp
Thorsten
T
Nephrology Div., Dept. of Internal Medicine, Rm. 1560, MSRB II, Univ. of Michigan Medical Ctr, Ann Arbor, MI 48109-0676, USA.
Kribben
Andreas
A
Roeser
Nancy F
NF
Senter
Ruth A
RA
Kemner
Sarah
S
Venkatachalam
Manjeri A
MA
Nissim
Itzhak
I
Weinberg
Joel M
JM
D058186:Acute Kidney Injury / Q000378:metabolism*; D000818:Animals; D002952:Citric Acid Cycle / Q000502:physiology; D003600:Cytosol / Q000378:metabolism; D042967:Electron Transport Complex I / Q000378:metabolism*; D004734:Energy Metabolism / Q000187:drug effects / Q000502:physiology; D005260:Female; D000860:Hypoxia / Q000378:metabolism; D007656:Ketoglutaric Acids / Q000378:metabolism; D007687:Kidney Tubules, Proximal / Q000201:enzymology*; D008293:Malates / Q000378:metabolism; D008928:Mitochondria / Q000201:enzymology*; D009243:NAD / Q000378:metabolism; D011817:Rabbits; D015427:Reperfusion Injury / Q000378:metabolism*; D012402:Rotenone / Q000494:pharmacology; D014475:Uncoupling Agents / Q000494:pharmacology
D007656:Ketoglutaric Acids; D008293:Malates; D014475:Uncoupling Agents; D012402:Rotenone; D009243:NAD; C030298:malic acid; D042967:Electron Transport Complex I